Author: http://www.marketwatch.com
Source: http://www.marketwatch.com
Interest: HemoShear, LLC, a biotechnology research company and leading developer of human and animal cell-based surrogate systems for discovery and assessment of new drug compounds, today announced that it has been awarded up to $4.3 million in a Phase II Small Business Innovation Research (SBIR) grant award from the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH)
Loading...